Table S4 from ETx-22, a Novel Nectin-4–Directed Antibody–Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4–Expressing Tumors
Authors:
- Marc LopezMLMarc Lopez
- Emerence CrompotECEmerence Crompot
- Emmanuelle JosselinEJEmmanuelle Josselin
- Anne FarinaAFAnne Farina
- Marion RubisMRMarion Rubis
- Remy CastellanoRCRemy Castellano
- Joanna FaresJFJoanna Fares
- Maria WehbeMWMaria Wehbe
- Yves ColletteYCYves Collette
- Emmanuelle CharafeECEmmanuelle Charafe
- Stéphanie BlanchinSBStéphanie Blanchin
- François RomagneFRFrançois Romagne
Open Access
- 16 March 2026
- other
- Published by American Association for Cancer Research (AACR)